Tag: Lineage Cell Therapeutics
Oligodendrocyte progenitor cells can be safely administered to patients in the...
Oligodendrocyte progenitor cells (LCTOPC1; Lineage Cell Therapeutics) can be safely administered to participants in the subacute period after cervical spinal cord injury (SCI), according...
Lineage set for clinical testing with OPC transplant therapy for spinal...
Biotechnology outfit Lineage Cell Therapeutics has announced that it will return to clinical testing with its investigational allogeneic oligodendrocyte progenitor cell (OPC) transplant therapy...